Hosted on MSN38m
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...
According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a ...
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback